DDX1, a member of the DEAD box RNA helicase family, plays a critical role in testicular tumors. However, it remains to be clarified whether DDX1 is involved in other types of malignant tumors such as colorectal cancer. We disrupted the DDX1 LGR5 by DDX1 knockdown was observed in 2 other human colorectal cancer cell lines, Colo320 and SW837. These results suggest that LGR5 is a critical effector of DDX1 in colorectal cancer cells. The DDX1-LGR5 axis could be a new drug target for this type of malignant cancer.
Aberrant activation of the Wnt signaling pathway is a main oncogenic driver in 90% of colorectal cancer patients with APC mutations. 4 In normal mucosa, the β-catenin level is kept low in the cytoplasm by the action of a destruction complex composed of glycogen synthase kinase 3, Axin1, casein kinase 1, APC and other factors. Mutations in APC abolish the destructive function, leading to the accumulation and nuclear translocation of β-catenin and subsequent transcriptional activation of its target genes, including LGR5, cMyc and Cyclin-D1.
5
LGR5, also known as GPR49, is a member of the G proteincoupled receptor (GPCR) family.
LGR5 was originally identified as a Wnt/Tcf4 target gene in colorectal cancer. 6 LGR5 is overexpressed in colorectal, 7 ovarian, 7 hepatocellular 8 and basal cell 9 cancers.
LGR5 expression was detected in human colorectal stem cells located between Paneth cells in the intestinal crypts. 10 Furthermore, cell lineage-tracing experiments demonstrated that LGR5-positive cells are intestinal cancer stem cells (CSC). 11 LGR5-positive intestinal stem cells are the cells of origin for adenoma caused by APC deletion 10, 11 and are present inside colorectal tumors in an Apc-KO mouse model.
12
DDX1 is a member of the DEAD box RNA helicase family characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD). DDX1
was originally identified by differential screening of a cDNA library enriched in transcripts present in a retinoblastoma cell line. 13 
DDX1
is coamplified with MYCN and overexpressed in a subset of neuroblastoma and retinoblastoma cell lines and tumors. 13, 14 DDX1 is involved in a variety of biological processes, including tRNA synthesis, 15 mRNA and microRNA processing, 16 ribosome biogenesis, DNA repair, 17 and nuclear factor-kappaB-mediated gene induction. 18 Because DDX1 deficiency in mice causes early embryonic lethality, it must play essential roles in normal cells.
19
DDX1 plays a critical role in testicular tumorigenesis in part by promoting transcription of Cyclin-D2 and stem cell-related genes on human chromosome 12p. 20 The expression level of DDX1 is elevated not only in germ cell tumors but also in retinoblastoma, neuroblastoma, glioblastoma and breast cancer. [21] [22] [23] [24] However, it remains unknown whether DDX1 plays a role in colorectal carcinogenesis.
In this study, we explored the function of DDX1 in human colorectal cancers by disrupting the DDX1 gene in a representative cell line LoVo.
We showed that DDX1-KO LoVo cells have defects in colony and sphere-forming capacity in vitro and in vivo tumorigenesis in nude mice.
More importantly, we demonstrated that DDX1 promotes the expression of the LGR5 gene by direct interaction with its enhancer/promoter region. Thus, DDX1 is an important regulator of colorectal CSC. This experiment was performed 3 times in triplicate.
| MATERIALS AND METHODS

| Cell culture
DDX1 5′-CAGAAGCCCTAGGTCCCAGA -3′ 5′-GAGCCAATCCATCTCTTCCA -3′ 287 LGR5 5′-TCCAACCTCAGCGTCTTCAC -3′ 5′-CGCAAGACGTAACTCCTCCA -3′ 111 CD133 5′-GAGTCGGAAACTGGCAGATAGCA -3′ 5′-ACGCCTTGTCCTTGGTAGTGTTG -3′ 113 ALDH1 5′-AGCCTTCACAGGATCAACAGA -3′ 5′-GTCGGCATCAGCTAACACAA -3′ 124 SOX2 5′-TGAGCGCCCTGCAGTACAA -3′ 5′-GCTGCGAGTAGGACATGCTGTAG -3′ 84 GAPDH 5′-GATCATCAGCAATGCCTCCT -3′ 5′-TTCAGCTCAGGGATGACCTT -3′ 240
| Western blot analysis
| Luciferase reporter assay
A genomic DNA sequence containing the human LGR5 gene was 
| Immunohistochemistry
Immunohistochemical staining was performed on formalin-fixed paraffin- 
| Immunofluorescence analysis
Cells were fixed with 2% paraformaldehyde and permeabilized with 0.1% Triton X-100. Cells were incubated with anti-DDX1 or anti-
LGR5 (ab75732, Abcam) antibody overnight at 4°C. They were stained with AlexaFluor 488-conjugated anti-rabbit IgG antibody (R37116, Thermo Fisher Scientific) and analyzed on a TSC SP8 Confocal microscope (Leica Microsystems, Mannheim, Germany).
| ChIP assay
A cross-linked chromatin fraction of LoVo cells was subjected to immunoprecipitation using anti-DDX1 or anti-rabbit IgG antibody (ab172730, Abcam) as previously described. 20 The amount of target genomic DNA in the immunoprecipitate was examined by real-time PCR on a LightCycler480. Sequence information of primers is shown in Table 2 .
| Statistical analysis
All statistical analyses were performed using Microsoft Excel. Differences between individual groups were analyzed using a 2-tailed unpaired t test. A P-value of <.05 was considered significant.
T A B L E 2 Primers used for ChIP analysis
Site
Forward primer Reverse primer Product (bp)
LGR5-P1
LGR5-P2 5′-GGCCCAGCTTGAATTACTCC -3′ 5′-TTCAACATGTGACCTGAGTGC -3′ 179 3 | RESULTS
| DDX1 is highly expressed in human colorectal cancer cell lines and tissues
We previously reported that DDX1 plays a critical role in testicular tumorigenesis using the human testicular germ cell tumor cell line, NEC8. 20 To examine whether DDX1 is also involved in colorectal carcinogenesis, we first compared the mRNA expression level of DDX1 in NEC8 cells with that in 5 human colorectal cancer cell lines by quantitative RT-PCR. DDX1 was highly expressed in all of these colorectal cancer cell lines, with expression as high as that in NEC8, and much higher than that in normal mouse colorectal tissue ( Figure 1A) . In LoVo cells, DDX1 protein was localized in both nucleus and cytoplasm ( Figure 1B) . Next, we investigated the expression of DDX1 protein in various histological subgroups of human F I G U R E 1 Expression of DDX1 in colorectal cancer cell lines and specimens. A, Expression levels of DDX1 mRNA in various human colorectal cancer cell lines were determined by quantitative RT-PCR. Mouse (m) colon and a human testicular germ cell line NEC8 were used as normal tissue and cancer controls, respectively. GAPDH levels were used for normalization. Each value represents the mean (n = 3) ± standard deviation (SD). B, Immunofluorescent staining of permeabilized LoVo cells by anti-DDX1 antibody followed by AlexaFluor 488-conjugated secondary antibody. Nuclei were counterstained with DAPI. Scale bars = 25 μm. C, Immunohistochemical staining of paraffinembedded sections of normal human colon and various stages of human colorectal adenocarcinomas. Scale bars = 50 μm. TNM grading of human colon cancers is as follows. M0, no distant metastasis; M1, distant metastasis; N0, no regional lymph node metastasis; N1, metastasis in 1-3 regional lymph nodes; N2, metastasis in 4 or more regional lymph nodes; T3, tumor invades through muscularis propria into subserosa or into nonperitonealized pericolic or perirectal tissues; T4, tumor directly invades other organs or structures and/or perforate visceral peritoneum colorectal cancer and normal colon. Strong signals for DDX1 were detected in these colorectal cancer patient specimens, whereas they were below the detection level in normal colorectal tissue (Figure 1C) . 
| DDX1 is required for density-independent and anchorage-independent growth of LoVo cells
We next compared growth capacity of WT, DDX1-KO and DDX1-KO + DDX1 LoVo cells under low cell density culture conditions.
WT and DDX1-KO + DDX1 cells grew to form cell islands, whereas DDX1-KO cells produced fewer and much smaller cell islands (Figure 3A) . The average size of DDX1-KO-derived cell islands was 16.3% that of WT cells, whereas that of DDX1-KO + DDX1-derived cell islands was 75.0% that of WT cells ( Figure 3A) .
Similar results were obtained in the soft agar colony formation assay. The average number of DDX1-KO-derived colonies was 28.1% that of the WT, whereas the number of DDX1-KO + DDX1-derived colonies was 79.4% that of the WT ( Figure 3B ). In addition, DDX1-KO-derived colonies in soft agar medium were smaller than WT-derived and DDX1-KO + DDX1-derived colonies ( Figure 3B ). Figure 4D ). These results demonstrate that DDX1 plays important roles in colorectal cancer progression.
| DDX1 is required for LGR5 expression in
LoVo cells
Because we previously found that DDX1 is a transcriptional acti- LGR5 by the DDX1 disruption and its rescue by exogenous DDX1
were detected at protein levels by western blotting ( Figure 5C ).
Quantification of the immunofluorescent intensity of LGR5 protein in the cells also revealed such a difference between WT or DDX1-KO + DDX1 and DDX1-KO cells ( Figure 5D ). These results demonstrated that DDX1 is indispensable for the expression of
LGR5 in LoVo cells.
LGR5 
| DISCUSSION
Here, we propose a critical function for DDX1 in colorectal carcinogenesis using the LoVo cell line as a model. We first showed that DDX1 mRNA is abundantly expressed in several human colorectal cancer cell lines. Previously, we reported the elevated expression of DDX1 in both seminoma and nonseminoma types of human testicular germ cell tumors. It is of note that Ddx1 is more abundantly expressed in spermatogonial stem cells than in differentiated spermatocytes in mouse testis. 20 Amplification and/or overexpression of the DDX1 gene has been described in retinoblastoma, 22 neuroblastoma, 24 glioblastoma 23 and breast cancer. 21 Furthermore, according In DDX1-KO LoVo cells, expression of LGR5, CD133, ALDH1 and SOX2 genes was suppressed. These are colorectal CSC markers. [26] [27] [28] [29] [30] Among them, LGR5 expression was fully restored by a high level of exogenously expressed DDX1. Expression of LGR5 was also repressed by DDX1 knockdown in Colo320 and SW837 cell lines.
Subsequently, we found that DDX1 directly binds to the enhancer/ promoter region of the human LGR5 gene and promotes its transcription. As is the case with DDX1, LGR5 is known to be required LGR5-positive cells are localized in the crypt base and invasive front areas. [37] [38] [39] Taken together, we propose that DDX1 regulates tumorigenic capacity and malignancy of colon cancer cells through the transcriptional regulation of the LGR5 gene in CSC.
The transcription factor GATA6 enhances the expression of
LGR5 in colorectal cancer cells by direct binding to its enhancer/promoter region. 40 In addition, GATA6 knockdown abrogates the tumorigenic capacity of colorectal cancer cells. In the enhancer/promoter region of the LGR5 gene, binding sites for GATA6 and DDX1
were distinct, suggesting that DDX1 is a second critical regulator of the LGR5 gene in colorectal cancer cells.
In summary, DDX1 plays important roles in in vitro colony formation and in vivo tumorigenesis of the human colorectal cancer cell line LoVo. DDX1 is involved in the transcriptional control of the
LGR5 gene, which is a functionally important CSC marker. Therefore, the DDX1-LGR5 axis is a new therapeutic target for colorectal cancers.
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